Counseling on the Interaction of Hormonal Contraceptives and Antiepileptics
NCT02485756 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2019-06-07
Summary
Previous studies have shown that women on anti-seizure medications are not informed about the pharmaceutical drug interactions between anti-seizure medications (antiepileptic drugs, AEDs) and certain hormonal contraceptive. The goal of this proposed study is to develop and assess the efficacy of an educational handout for participants on the ways AEDs and certain hormonal contraceptives can interact to alter effectiveness of the medications. Reproductive age women (18-45 years old) will be recruited from UCSD Health System Epilepsy clinics. If a patient agrees to participate, she will be given a knowledge exam prior to the clinic appointment to establish baseline understanding of hormonal contraceptive and AED interactions and then the participant will be randomized to receive the intervention (educational handout) or the standard of care (no educational handout). Those in participants in the intervention group will read an educational handout on hormonal contraceptives/AED interactions. Those in the standard care group will not receive this handout and the same knowledge exam will be re-administered to all of the participants after they have completed their appointments to check for knowledge comprehension and short-term knowledge retention. A same-day post-test questionnaire will evaluate participant's intention to discuss hormonal contraceptives/AED interactions with their gynecologist, neurologist or primary care physician.
Conditions
Interventions
- OTHER
-
Educational handout
Topics include: interactions between AED and certain hormonal contraceptives, Center for Disease Control and Prevention (CDC) recommendations for alternative contraceptive methods that are not known to interact with AEDs, contraceptive failure rates
Sponsors & Collaborators
-
University of California, San Diego
lead OTHER
Principal Investigators
-
Sheila Mody, MD · UC San Diego
-
Marisa Hildebrand, MPH · UCSD
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-06-30
- Primary Completion
- 2014-05-31
- Completion
- 2014-05-31
Countries
- United States
Study Locations
More Related Trials
-
Lamotrigine and Oral Contraceptives
NCT00266149 ·Status: TERMINATED ·Phase: PHASE3
-
Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy
NCT00021866 ·Status: COMPLETED
-
Effect of Repeat Administration of Eslicarbazepine Acetate on the Pharmacokinetics of a Combined Oral Contraceptive
NCT00898560 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
NCT02914314 ·Status: COMPLETED ·Phase: PHASE2
-
Adherence to Pharmacological Antiepileptic Treatment in Adolescence
NCT05825807 ·Status: UNKNOWN
-
Epilepsy Birth Control Registry
NCT01097837 ·Status: UNKNOWN
-
Progesterone vs Placebo Therapy for Women With Epilepsy
NCT00029536 ·Status: COMPLETED ·Phase: PHASE3
-
Enhancing Antiepileptic Drug Adherence
NCT02165306 ·Status: COMPLETED ·Phase: NA
-
Enhancing Medical Compliance and Health-related Quality of Life of Patients With Epilepsy
NCT02547389 ·Status: COMPLETED ·Phase: NA
-
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)
NCT01730170 ·Status: COMPLETED
-
Safety and Tolerability Study of Diazepam Buccal Film (DBF) in Subjects With Epilepsy
NCT03428360 ·Status: COMPLETED ·Phase: PHASE3
-
Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy
NCT00043914 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of Anti-epileptic Drugs in Obese Children
NCT02993861 ·Status: COMPLETED
-
Medication Adherence in Individuals With Epilepsy
NCT01566500 ·Status: COMPLETED
-
The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children
NCT05697614 ·Status: UNKNOWN ·Phase: PHASE4
-
Role of Hormones in Susceptibility to Seizures in Women With Epilepsy
NCT00044252 ·Status: COMPLETED
-
Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs
NCT01527006 ·Status: COMPLETED ·Phase: PHASE2
-
Standardized Educational Plan for Epilepsy Patients With Comorbidities
NCT01804322 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Diazepam Buccal Film Administered in the Interictal and in the Ictal-Periictal States to Adults With Epilepsy
NCT03179891 ·Status: COMPLETED ·Phase: PHASE2
-
Study The Knowledge and Attitude Towards Epilepsy Among Relatives of People With Epilepsy and Their Impact on The Patient's Quality of Life
NCT05671575 ·Status: UNKNOWN
-
Pharmacokinetics and Safety Study of Diazepam Buccal Film (DBF) in Pediatric Subjects With Epilepsy
NCT03222349 ·Status: COMPLETED ·Phase: PHASE2
-
Diazepam Trial in GAD65 Associated Epilepsy
NCT05361447 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Web-based Intervention to Improve Executive Functioning in Teens With Epilepsy (Epilepsy Journey)
NCT02925663 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
NCT02535091 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study of Topiramate in Childhood Absence Epilepsy
NCT00210574 ·Status: COMPLETED ·Phase: PHASE2